President
CurrentFuture Medical Services, LLC (FMS) was formed in anticipation of FDA Clearance of the OrthoGold Low Intensity SoftWave Device. FDA Clearance was received on December 21 2018. FMS is one of the initial distributors for Tissue Regeneration Technologies, LLC (TRT) and will focus efforts on servicing the Urology, OBGYN, Orthopedics, and Sports Medicine.